1. Home
  2. IMRN vs CPOP Comparison

IMRN vs CPOP Comparison

Compare IMRN & CPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • CPOP
  • Stock Information
  • Founded
  • IMRN 1994
  • CPOP 2007
  • Country
  • IMRN Australia
  • CPOP China
  • Employees
  • IMRN N/A
  • CPOP N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • CPOP Services-Misc. Amusement & Recreation
  • Sector
  • IMRN Health Care
  • CPOP Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • CPOP Nasdaq
  • Market Cap
  • IMRN 9.2M
  • CPOP 9.5M
  • IPO Year
  • IMRN N/A
  • CPOP 2021
  • Fundamental
  • Price
  • IMRN $1.72
  • CPOP $0.80
  • Analyst Decision
  • IMRN Strong Buy
  • CPOP
  • Analyst Count
  • IMRN 1
  • CPOP 0
  • Target Price
  • IMRN $5.00
  • CPOP N/A
  • AVG Volume (30 Days)
  • IMRN 656.2K
  • CPOP 3.1M
  • Earning Date
  • IMRN 09-08-2025
  • CPOP 08-05-2025
  • Dividend Yield
  • IMRN N/A
  • CPOP N/A
  • EPS Growth
  • IMRN N/A
  • CPOP N/A
  • EPS
  • IMRN N/A
  • CPOP N/A
  • Revenue
  • IMRN $4,048,286.00
  • CPOP $65,186,721.00
  • Revenue This Year
  • IMRN N/A
  • CPOP N/A
  • Revenue Next Year
  • IMRN N/A
  • CPOP N/A
  • P/E Ratio
  • IMRN N/A
  • CPOP N/A
  • Revenue Growth
  • IMRN 82.90
  • CPOP 108.29
  • 52 Week Low
  • IMRN $1.50
  • CPOP $0.46
  • 52 Week High
  • IMRN $2.87
  • CPOP $1.62
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 45.31
  • CPOP 61.42
  • Support Level
  • IMRN $1.60
  • CPOP $0.56
  • Resistance Level
  • IMRN $1.80
  • CPOP $0.86
  • Average True Range (ATR)
  • IMRN 0.10
  • CPOP 0.11
  • MACD
  • IMRN -0.01
  • CPOP 0.02
  • Stochastic Oscillator
  • IMRN 34.09
  • CPOP 55.92

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About CPOP Pop Culture Group Co. Ltd

Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.

Share on Social Networks: